LOGIN  |  REGISTER
Terns Pharmaceuticals

List of Healthcare Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 308.55
0.99 0.32
5.09M
920.28M
US$ 283.950B
US$ 376.00
-2.04 -0.54
580,865
253.30M
US$ 95.240B
US$ 321.75
1.36 0.42
581,668
278.15M
US$ 89.490B
US$ 67.26
0.66 0.99
2.23M
1.26B
US$ 84.750B
US$ 348.00
-2.25 -0.64
1.48M
231.92M
US$ 80.710B
US$ 284.00
1.39 0.49
578,952
162.35M
US$ 46.110B
US$ 76.07
-0.05 -0.07
1.57M
456.87M
US$ 34.750B
US$ 239.00
-4.79 -1.96
631,447
120.41M
US$ 28.780B
US$ 33.24
-0.54 -1.60
29.27M
504.86M
US$ 16.780B
US$ 28.12
-0.20 -0.71
83,793
586.83M
US$ 16.500B
US$ 171.50
-0.72 -0.42
661,208
95.10M
US$ 16.310B
US$ 240.97
1.97 0.82
632,303
57.20M
US$ 13.780B
US$ 77.01
-1.24 -1.58
297,404
172.76M
US$ 13.300B
US$ 119.04
0.16 0.13
191,091
100.75M
US$ 11.990B
US$ 140.04
-2.52 -1.77
381,591
82.02M
US$ 11.490B
US$ 182.37
-2.13 -1.15
451,201
58.71M
US$ 10.710B
US$ 11.49
0.00 0.00
6.65M
864.15M
US$ 9.930B
US$ 102.10
0.82 0.81
532,446
86.66M
US$ 8.850B
US$ 150.17
1.26 0.85
329,232
57.30M
US$ 8.600B
US$ 61.00
1.69 2.85
549,423
128.14M
US$ 7.820B
US$ 474.80
3.56 0.76
63,708
14.98M
US$ 7.110B
US$ 39.34
0.67 1.73
421,075
172.09M
US$ 6.770B
US$ 14.31
0.00 0.00
0
422.39M
US$ 6.040B
US$ 30.50
-0.53 -1.71
510,032
170.18M
US$ 5.190B
US$ 22.12
0.12 0.55
1.91M
174.13M
US$ 3.850B
US$ 16.53
-0.09 -0.54
25.64M
211.76M
US$ 3.500B
US$ 96.10
0.14 0.15
683,492
32.75M
US$ 3.150B
US$ 22.15
0.13 0.59
1.37M
127.11M
US$ 2.820B
US$ 13.57
-0.04 -0.29
3.74M
191.70M
US$ 2.600B
US$ 21.55
-0.37 -1.69
715,888
120.00M
US$ 2.590B
US$ 90.00
0.29 0.32
328,086
27.47M
US$ 2.470B
US$ 23.02
-0.17 -0.73
2.52M
92.89M
US$ 2.140B
US$ 21.99
0.26 1.20
2.65M
96.11M
US$ 2.110B
US$ 13.35
0.31 2.38
262,270
155.18M
US$ 2.070B
US$ 111.86
1.27 1.15
167,924
18.13M
US$ 2.030B
US$ 15.76
0.63 4.16
176,553
128.99M
US$ 2.030B
US$ 13.39
-0.03 -0.22
112,448
142.73M
US$ 1.910B
US$ 4.90
0.12 2.51
1.35M
382.64M
US$ 1.870B
US$ 21.46
0.22 1.04
1.13M
85.15M
US$ 1.830B
US$ 11.33
-0.16 -1.39
1.11M
160.99M
US$ 1.820B
US$ 28.99
-0.09 -0.31
150,087
58.12M
US$ 1.680B
US$ 108.44
-0.32 -0.29
25,498
15.44M
US$ 1.670B
US$ 8.25
-0.10 -1.20
3.22M
172.17M
US$ 1.420B
US$ 29.57
-0.23 -0.77
146,087
46.32M
US$ 1.370B
US$ 12.76
-0.25 -1.92
3.82M
107.00M
US$ 1.370B
US$ 11.87
0.14 1.19
916,822
115.03M
US$ 1.370B
US$ 6.76
-0.12 -1.74
1.05M
199.21M
US$ 1.350B
US$ 21.09
0.13 0.62
339,459
63.69M
US$ 1.340B
US$ 20.85
0.26 1.26
49,380
63.29M
US$ 1.320B
US$ 80.50
-0.17 -0.21
168,182
15.10M
US$ 1.220B
US$ 13.78
0.00 0.00
131,209
85.88M
US$ 1.180B
US$ 25.28
0.63 2.56
290,510
45.65M
US$ 1.150B
US$ 15.36
0.42 2.81
501,547
73.29M
US$ 1.130B
US$ 2.58
-0.01 -0.39
6.43M
412.08M
US$ 1.060B
C$ 4.25
0.01 0.24
2.36M
248.96M
C$ 1.060B
US$ 6.38
-0.31 -4.63
19,759
162.86M
US$ 1.040B
US$ 2.43
0.05 2.10
2.12M
412.02M
US$ 1.000B
US$ 26.30
0.40 1.54
140,679
34.35M
US$ 903.400M
US$ 4.65
0.19 4.26
909,341
193.22M
US$ 898.470M
US$ 27.80
0.05 0.18
77,432
30.41M
US$ 845.400M
US$ 22.00
-0.01 -0.05
246,331
38.07M
US$ 837.540M
US$ 120.00
-2.29 -1.87
326,129
5.44M
US$ 652.800M
US$ 4.46
0.31 7.47
56,281
135.46M
US$ 604.150M
C$ 10.78
-0.11 -1.01
130,386
52.61M
C$ 567.140M
US$ 6.89
0.00 0.00
0
81.68M
US$ 562.780M
US$ 1.43
0.00 0.00
0
371.88M
US$ 531.790M
US$ 4.70
0.00 0.00
0
107.64M
US$ 505.910M
US$ 4.80
-0.26 -5.14
2.83M
104.27M
US$ 500.500M
US$ 25.47
0.55 2.21
9,746
19.07M
US$ 485.710M
US$ 29.20
0.00 0.00
0
16.17M
US$ 472.160M
US$ 3.36
-0.07 -2.04
856,521
138.95M
US$ 466.870M
US$ 4.03
0.01 0.25
438,745
115.52M
US$ 465.550M
US$ 2.75
0.12 4.56
1.16M
168.92M
US$ 464.530M
US$ 7.75
0.04 0.52
790,376
50.28M
US$ 389.670M
C$ 16.58
0.33 2.03
155,181
23.40M
C$ 387.970M
US$ 17.83
0.42 2.41
126,384
20.27M
US$ 361.410M
US$ 17.95
-0.41 -2.23
460,816
20.09M
US$ 360.620M
US$ 13.01
-0.79 -5.72
908
27.08M
US$ 352.310M
US$ 22.85
0.19 0.84
161,444
14.93M
US$ 341.150M
US$ 5.25
0.09 1.74
646,104
57.88M
US$ 303.870M
US$ 3.24
-0.09 -2.73
6.30M
86.02M
US$ 278.620M
US$ 13.50
0.40 3.05
147,875
18.42M
US$ 248.670M
US$ 4.06
0.00 0.00
570,712
60.85M
US$ 247.050M
C$ 1.32
-0.05 -3.65
386,377
165.88M
C$ 218.960M
US$ 2.99
-0.06 -1.97
125,934
66.44M
US$ 198.660M
US$ 6.33
0.02 0.32
9,050
30.00M
US$ 189.900M
US$ 2.48
0.04 1.64
1.57M
75.56M
US$ 187.390M
C$ 2.94
0.01 0.34
26,380
63.49M
C$ 186.660M
US$ 11.69
-0.07 -0.60
33,628
14.98M
US$ 175.120M
US$ 7.50
-0.18 -2.34
3,016
23.12M
US$ 173.400M
US$ 1.55
-0.02 -1.27
655,875
101.53M
US$ 157.370M
US$ 24.94
0.00 0.00
0
5.98M
US$ 149.140M
US$ 4.22
0.03 0.72
52,178
31.11M
US$ 131.280M
US$ 3.38
-0.14 -3.98
63,727
37.15M
US$ 125.570M
US$ 8.78
0.14 1.62
29,289
13.67M
US$ 120.020M
US$ 2.35
0.00 0.00
0
49.43M
US$ 116.160M
US$ 3.76
0.02 0.53
375,948
26.35M
US$ 99.080M
C$ 1.33
-0.01 -0.75
63,352
74.08M
C$ 98.530M
US$ 1.04
-0.05 -4.59
229,344
73.84M
US$ 76.790M
US$ 1.96
-0.01 -0.51
5,557
31.02M
US$ 60.800M
US$ 6.87
0.01 0.15
1,400
8.29M
US$ 56.950M
US$ 3.21
0.07 2.23
438,286
14.28M
US$ 45.840M
US$ 5.05
-0.05 -0.98
5,168
8.06M
US$ 40.700M
US$ 2.39
-0.06 -2.41
159,046
16.26M
US$ 38.880M
US$ 2.05
0.00 0.00
0
16.39M
US$ 33.600M
US$ 1.17
-0.01 -0.85
14,271
24.67M
US$ 28.860M
US$ 1.08
-0.03 -2.70
35,581
22.41M
US$ 24.200M
C$ 0.27
0.00 0.00
0
86.21M
C$ 23.280M
US$ 5.20
-0.005 -0.10
142,640
4.27M
US$ 22.180M
US$ 1.36
-0.02 -1.45
520
14.36M
US$ 19.530M
US$ 0.21
0.00 0.00
0
82.96M
US$ 17.180M
US$ 2.49
0.06 2.47
3,014
6.42M
US$ 15.990M
US$ 5.62
0.00 0.00
0
2.82M
US$ 15.850M
US$ 0.56
-0.07 -11.11
188,776
27.99M
US$ 15.670M
C$ 0.26
0.01 4.00
32,914
56.40M
C$ 14.660M
US$ 1.68
0.10 6.33
108,587
8.71M
US$ 14.630M
C$ 0.13
0.00 0.00
0
93.47M
C$ 11.680M
US$ 0.91
0.004 0.44
62,493
7.04M
US$ 6.410M
US$ 2.77
0.00 0.00
0
1.88M
US$ 5.220M
C$ 0.80
0.10 14.29
11,450
6.40M
C$ 5.120M
C$ 0.04
0.00 0.00
0
133.13M
C$ 4.660M
US$ 0.36
0.00 0.00
0
12.75M
US$ 4.590M
US$ 0.99
-0.01 -1.00
1,333
4.22M
US$ 4.180M
US$ 1.55
0.03 1.97
107,663
2.49M
US$ 3.860M
C$ 0.07
0.02 44.44
10,000
55.51M
C$ 3.610M
US$ 0.50
0.02 3.31
1.01M
4.22M
US$ 2.110M
US$ 0.55
0.00 0.00
0
3.13M
US$ 1.720M
US$ 0.42
0.00 0.00
0
3.81M
US$ 1.610M
C$ 0.02
0.00 0.00
0
47.62M
C$ 952K
C$ 0.01
0.00 0.00
0
89.59M
C$ 896K
C$ 0.01
0.00 0.00
0
87.10M
C$ 871K
C$ 0.005
0.00 0.00
0
173.26M
C$ 866K
US$ 0.44
-0.02 -5.19
209,879
1.86M
US$ 818K
US$ 0.08
-0.02 -23.08
105,502
8.97M
US$ 718K
US$ 0.03
0.0011 4.42
136.79M
5.67M
US$ 147K
US$ 0.00
-0.0003 -100.00
550
19.73M
US$ -
US$ 0.00
0.00 0.00
0
37.67M
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -

Latest Healthcare Stock News


Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

High-Volume Hemodiafiltration is used for the first time in seven out of 10 CCINSHAE centers in Mexico In Mexico, 240 CCINSHAE patients are now being treated; more than 410 regular patients also treated Fresenius Medical Care is committed to expanding HighVolumeHDF therapy to all markets where it is not already present, including the United States BAD HOMBURG, Germany, July 3, 2025 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products... Read more


symplr Acquires AMN Healthcare's Smart Square Scheduling Software, Enhancing AI-Driven Workforce Optimization for Health Systems

Strengthening symplr's commitment to helping providers optimize staffing, operations, and outcomes HOUSTON, July 2, 2025 /PRNewswire/ -- symplr®, a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners LLC (together with its affiliates, "Charlesbank"), has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE: AMN). This... Read more


Ensign Purchases Skilled Nursing Facility in Texas

SAN JUAN CAPISTRANO, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that through a subsidiary of Standard Bearer Healthcare REIT, Inc., Ensign’s captive real estate company,... Read more


PanGenomic Health Announces Financial Results for the 2024 Fiscal Year

Vancouver, British Columbia, Canada – TheNewswire - July 2, 2025 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it has filed its audited annual consolidated financial statements for the financial year ended December 31, 2024 (the “2024 Year End Financial Statements”). The 2024 Year End Financial Statements, together with detailed information regarding the Company's financial results as set forth in the Company's... Read more


Pennant Announces Home Health Acquisition in Southern California

EAGLE, Idaho, July 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of a premier home health agency, GrandCare Health Services. The newly acquired agency, to be known as GrandCare Home Health, provides services in Los Angeles, Orange, Riverside and San Diego counties in California, and broadens Pennant’s service... Read more


DocGo to Provide Medical Transportation Services to Albany Stratton VA Medical Center

NEW YORK / Jul 01, 2025 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that its Ambulnz subsidiary was awarded a multi-year $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center. Under the contract, Ambulnz by DocGo will provide basic life support, advanced life support and critical... Read more


Pediatrix Medical Board Appoints Kurt D. Newman, M.D. as Independent Director

FORT LAUDERDALE, Fla. / Jul 01, 2025 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children’s National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective... Read more


The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada

CERRITOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI”), one of the largest value-based oncology groups in the United States, announced today that effective July 1, it will be the exclusive oncology provider for over 80,000 Medicaid patients associated with SilverSummit Healthplan in Nevada. TOI is known for bringing state-of-the-art cancer care to the communities it serves, and their presence in the Las Vegas market will... Read more


Premier Expands Clinical Decision Support (CDS) Capabilities with Acquisition of IllumiCare

IllumiCare’s cost attribution technology defines low-value care and makes costs transparent in real time, enabling improved financial performance. Compatible with 50-plus electronic medical record (EMR) systems, taps into a growing demand for solutions in outpatient and ambulatory settings. Unlocks potential growth opportunities across Premier’s service lines including clinical trial optimization, revenue cycle improvement and value-based consulting. CHARLOTTE,... Read more


Select Medical Signs Agreement with Ballad Health to Operate Joint Venture Critical Illness Recovery Hospital

MECHANICSBURG, Pa., June 27, 2025 /PRNewswire/ -- Select Medical Corporation today announced it signed a membership interest purchase agreement with Ballad Health to jointly operate Select Specialty Hospital – Tri-Cities, a critical illness recovery hospital in Kingsport, Tenn. The facility, licensed as long-term acute care, will be a hospital-in-hospital located in Ballad Health's Indian Path Community Hospital.  Select Medical will serve as the majority owner... Read more


Schrödinger Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia

Demonstrates the potential of SGR-1505 as a novel approach for diseases with high unmet medical need NEW YORK / Jun 27, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that SGR-1505, its clinical stage MALT1 inhibitor, was designated as a Fast Track product by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Waldenström macroglobulinemia that have failed at least two lines of therapy, including a Bruton’s... Read more


Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results

Third quarter financial results Third quarter loss per share1 was $0.20 compared to earnings per share of $0.40 in the year-ago quarter. The decline in earnings per share was primarily driven by prior year after-tax gains related to fair value adjustments on variable prepaid forward derivatives and a partial sale of the Company's equity method investment in Cencora, and higher tax expense in the current quarter. Adjusted earnings per share (EPS)2 was $0.38 compared to... Read more


Veeva Systems and AWS Expand 10-Year Relationship

AWS compute, database, and global infrastructure support Veeva’s industry cloud for life sciences PLEASANTON, Calif. & SEATTLE / Jun 25, 2025 / Business Wire / Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Veeva Systems (NYSE: VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva is using AWS as the cloud in... Read more


GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Data demonstrates that rapid genomic testing dropped the average time to a precise genetic diagnosis from almost ten months to 13 days Despite broad utilization in the study, rapid genomic sequencing in non-critical care inpatients yielded a diagnostic rate over 42%, comparable to critical care settings Study supports broader adoption of rapid genomic testing in the non-critical care inpatient setting to improve pediatric patient outcomes and lower healthcare costs... Read more


Wellgistics Health Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform. This expansion reflects Wellgistics' accelerating momentum in creating a modern drug ecosystem-one... Read more


First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) Company reaffirms internal... Read more


FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid in the brain This approval also enables clinicians to use Vizamyl to monitor patient response to anti-amyloid therapies Other updates include now enabling the use of Vizamyl to predict development of dementia or other cognitive decline due to Alzheimer’s disease, selecting patients who are indicated... Read more


Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health

With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding pelvic floor therapy to its comprehensive offering of women’s health and family building solutions. With the expansion of its network of... Read more


WELL Health Technologies Announces Availability for 45,000 New Primary Care Patients Across 3 Provinces Enabled by Investments in Physician Recruitment and Digital Transformation

WELL Health has added over 45,000 new primary care patient openings across its national clinic network, providing immediate relief in high-demand regions including Ontario, Alberta, and Manitoba. Patients would require their valid provincial health card(1) to be eligible and can sign up through our national patient registration website at https://newpatients.wellclinics.ca/. The expansion is made possible through investments made by WELL in the recruitment and onboarding... Read more


Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think Tank BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation... Read more


OneMedNet Announces Additional $3.7 Million of Funding in Private Placement Transactions and Approximately $11 Million in Reductions in Liabilities

MINNEAPOLIS, June 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that it has entered into agreements with accredited investors in private placement transactions at $0.42 per share of common stock that resulted in gross proceeds of approximately $3.7 million, before deducting fees and expenses payable by the Company. Certain... Read more


Celia Huber Joins AMN Healthcare Board of Directors

Huber brings more than 30 years of experience across multiple sectors DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, announced the election of Celia Huber to its Board of Directors during its annual meeting of shareholders on May 2, 2025. Huber’s background includes more than 30 years of experience advising healthcare systems, public and private sector payors... Read more


OptimizeRx Appoints CEO Steve Silvestro to Board of Directors

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025. Mr. Silvestro joined the Company in 2019 and... Read more


GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

A milestone in pediatric medicine, general pediatricians are now expected to play a more active role in initiating genetic testing Earlier use of exome and genome testing delivers better clinical outcomes and reduces costs across the U.S. healthcare system1 GeneDx will lead education and adoption efforts to end the diagnostic odyssey GAITHERSBURG, Md. / Jun 23, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic... Read more


GeneDx: Galatea Bio and Fabric Genomics Partner to Deliver Comprehensive Genetic Testing for Common Diseases

MIAMI & OAKLAND, Calif. / Jun 23, 2025 / Business Wire / Galatea Bio and Fabric Genomics, a GeneDx company, announced today a strategic collaboration to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases. The initial offering will include an inherited cardiovascular gene panel based on American Heart Association (AHA) recommendations, with additional PRS for... Read more


NetraMark's AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials has released a new preprint on arXiv demonstrating that its flagship AI platform, NetraAI, has substantially outperformed leading large language models, DeepSeek and ChatGPT. NetraAI also outperformed traditional machine learning techniques... Read more


GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025

GE HealthCare continues to advance precision care in cardiology through innovative molecular imaging solutions to help support early diagnosis, tailored treatments, and improved patient outcomes. CHICAGO / Jun 23, 2025 / Business Wire / GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New... Read more


BullFrog AI’s Dr. Juan Felipe Beltrán to Highlight Advanced AI Strategies in Bioinformatics at XTalks Webinar

GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that Dr. Juan Felipe Beltrán, Director of AI, Machine Learning, and Innovation, will be the featured speaker at the upcoming XTalks webinar: AI... Read more


Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine

GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT) technology for new clinical pathways to help improve patient outcomes. Total body PET/CT technologyi is designed with the goal of supporting personalized medicine practices like theranostics, improve healthcare system efficiency, and provide scalable solutions for imaging practices and healthcare facilities. CHICAGO /... Read more


VitalHub Completes Acquisition of Induction

TORONTO, June 19, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announced that it has completed the cash acquisition of Induction Healthcare Group PLC (“Induction”) by way of a court-sanctioned scheme of arrangement (the “Acquisition”) under Part 26 of the Companies Act 2006. For full details related to the Acquisition, please see the circular related to the scheme of arrangement published by Induction on... Read more


Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in North Las Vegas

BIRMINGHAM, Ala. and LAS VEGAS, June 18, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in North Las Vegas, Nevada. The hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24-hour nursing... Read more


BrightSpring Health Services Announces Onco360® Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs

LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services (“BrightSpring” or “BrightSpring Health Services”) (NASDAQ: BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy partner for several newly approved therapies in the treatment of advanced cancers and rare genetic disorders. Onco360® will help provide access, education, data, and expert support for innovative treatments for... Read more


Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promises SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada’s GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence... Read more


Waystar Appoints Aashima Gupta and Michael Roman to Board of Directors

New directors bring deep expertise in AI innovation, healthcare, and enterprise growth LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the appointment of two accomplished leaders, Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman of the Board and Chief Executive Officer... Read more


Streamline Health Solutions Reports Fiscal First Quarter 2025 Financial Results

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced financial results for the fiscal first quarter of 2025 which ended April 30, 2025. Fiscal First Quarter Financial Results Total revenue for the first quarter of fiscal 2025 increased... Read more


Mobile-health Network Solutions Announces H1 FY2025 Results; Continues on Drive Towards Scale and Profitability

Singapore, Singapore--(Newsfile Corp. - June 16, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced financial results for the first six months of its fiscal year 2025 ("H1 FY2025"). H1 FY2025 performance: Short-term impact from transition to leaner, stronger model For the period ended December 31, 2024, the company reported: Revenue of US$4.3... Read more


GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions

GE HealthCare expands precision care capabilities with its first combined software release with MIM Encore™, helping enhance digital imaging and workflow solutions across oncology, cardiology, and neurology. The software solution was designed to help tackle key healthcare challenges like improving efficiency, streamlining cross-departmental communication, and reducing manual workloads. Now powered with additional GE HealthCare features and algorithms, MIM Encore delivers... Read more


NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence (AI) solutions company transforming clinical trial design in the pharmaceutical industry through streamlined access to actionable analytics uncovered by AI, today announced that NetraMark founder Dr. Joseph Geraci was the lead author on a new publication that outlines the market opportunity for... Read more


BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients

GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced a strategic collaboration with Sygnature Discovery, a leading UK-based contract research organization (CRO) specializing in drug discovery. Through... Read more


Schrödinger Reports Encouraging Initial Phase 1 Clinical Data for SGR-1505 at EHA Annual Congress

SGR-1505 was observed to have a favorable safety profile and was well tolerated, with encouraging preliminary efficacy in patients with relapsed/refractory B-cell malignancies Responses observed across a broad range of B-cell malignancies, including monotherapy responses in patients with CLL and Waldenström macroglobulinemia Management to host a webcast today at 8:00 a.m. ET MILAN / Jun 12, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced... Read more


Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience

New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeys As new data show 4 out of 5 U.S. adults don't feel confident in their knowledge of health insurance benefits, new digital tools use clear, conversational language to boost understanding and help customers get more out of their coverage BLOOMFIELD, Conn., June 12, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna... Read more


Simulations Plus Announces Preliminary Third Quarter Fiscal 2025 Revenue

Updates fiscal 2025 revenue guidance range Third quarter fiscal 2025 full results to be released on July 2, 2025, with conference call at 5 p.m. ET RESEARCH TRIANGLE PARK, N.C. / Jun 11, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced... Read more


Brookdale Senior Living Files Investor Presentation Highlighting Board's Effective Oversight of Clear, Compelling Strategy to Deliver Long-Term Shareholder Value

Brookdale's Significantly Refreshed Board Has Critical Skillsets and Experience Necessary to Drive the Company's Success Ortelius' Attempt to Take Control of the Company Risks Value Destruction, Disrupting Brookdale's Continued Operational Progress and CEO Search Ortelius Does Not Have a Substantially Different Strategic Plan or a Board Slate with a Diversified Skillset Relevant to Brookdale's Strategy The Company Urges Shareholders to Vote "FOR" ONLY the Eight Brookdale... Read more


Medtech Industry Establishes Foundation for Clinical Trials with Veeva Systems MedTech

More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif., June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clinical Platform applications to simplify and streamline medical device... Read more


HEALWELL AI Leverages Orion Health to Power Entry into US Market

HEALWELL launches in the U.S. market a suite of AI enabled tools to complement Orion Health's established software offerings in the U.S. This will bring together HEALWELLs globally validated AI capabilities with Orion Health's best-in-class health data infrastructure software creating a unique offering for the U.S. market. This U.S. market launch leverages Orion Health's deep U.S. sector experience, existing U.S. footprint and multi-decade track record of delivering... Read more


AirSculpt Technologies Announces Closing of Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

MIAMI BEACH, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced the closing of its previously announced underwritten public offering of 3,160,000 shares of common stock. In addition, the underwriter has exercised in full its option to purchase an additional 474,000 shares of common stock. The proceeds from the offering, after... Read more


WELL Health Technologies: CRH Medical and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery

Collaboration merges clinical and operational expertise with virtual-first innovation to eliminate barriers to GI care. ATLANTA & CHICAGO / Jun 10, 2025 / Business Wire / CRH Medical Corporation (“CRH”), a leading provider of products and services for gastrointestinal (GI) providers and a wholly owned subsidiary of WELL Health Technologies Corp. (“WELL”), has announced a strategic partnership with WovenX Health (“WovenX”), a leader in integrated virtual... Read more


Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence... Read more


BrightSpring Health Services Announces Secondary Offering of Common Stock

LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the “KKR Selling Stockholder”) and certain members of management, intend to offer for sale... Read more


Brookdale Senior Living Reports May 2025 Occupancy

NASHVILLE, Tenn., June 9, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) reported today its consolidated occupancy for May 2025. May 2025 Observations: May consolidated weighted average occupancy grew 190 basis points year-over-year and 20 basis points sequentially to 80.0%, achieving a critical milestone for the consolidated portfolio. Driven by strong move-in volume and disciplined sales execution, May same community weighted average occupancy... Read more